# ALYMSYS
> **BLA761231** · Biologics License Application · Sponsor: AMNEAL PHARMS LLC · Approved 2022-04-13
## Drug
- **FDA Application Number:** BLA761231
- **Application type:** Biologics License Application
- **Brand name:** ALYMSYS
- **Generic name:** BEVACIZUMAB-MALY
- **Active ingredients:** BEVACIZUMAB-MALY
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL PHARMS LLC
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2022-04-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761231)
---
*AI Analytics · CC0 1.0*